Characterization of pneumolysin from Streptococcus pneumoniae, interacting with carbohydrate moiety and cholesterol as a component of cell membrane

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 659-663

  Lim, Jong Eun ^a   Park, Seong Ah ^a   Bong, Seoung Min ^b   Chi, Young Min ^b   Lee, Ki Seog ^a  

^a Catholic University of Pusan   (South Korea)

^b Korea University   (South Korea)

Author keywords

Carbohydrate moiety; Cholesterol dependent cytolysin; Mannose; Pneumolysin

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; CYTOLYSIN; MANNOSE; PNEUMOLYSIN;

ARTICLE; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; DOSE RESPONSE; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

BACTERIAL PROTEINS; CELLS, CULTURED; CHOLESTEROL; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; GALACTOSE; GLUCOSE; HUMANS; MANNOSE; RECOMBINANT PROTEINS; STREPTOLYSINS; WATER;

STREPTOCOCCUS PNEUMONIAE;

EID: 84872358998     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.095     Document Type: Article

References (31)

1. Kramer M.R., Rudenskys B., Hadas-Halperin I., Isacsohn M., Melzer E. Pneumococcal bacteremia - no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr. J. Med. Sci. 1987, 23:174-180.
2. Hook 3rd E.W., Horton C.A., Schaberg D.R. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983, 249:1055-1057.
3. Rubins J.B., Janoff E.N. Pneumolysin: a multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 1998, 131:21-27.
4. Mitchell T.J. Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res. Microbiol. 2000, 151:413-419.
5. Walker J.A., Allen R.L., Falmagne P., Johnson M.K., Boulnois G.J. Molecular cloning characterization and complete nucleotide sequence of the gene for pneumolysin the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 1987, 55:1184-1189.
6. Tweten R.K. Cholesterol-dependent cytolysins a family of versatile pore-forming toxins. Infect. Immun. 2005, 73:6199-6209.
7. Shepard L.A., Heuck A.P., Hamman B.D., Rossjohn J., Parker M.W., Ryan K.R., Johnson A.E., Tweten R.K. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 1998, 37:14563-14574.
8. Nagamune H., Ohnishi C., Katsuura A., Fushitani K., Whiley R.A., Tsuji A., Matsuda Y. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect. Immun. 1996, 64:3093-3100.
9. Bhakdi S., Tranum-Jensen J., Sziegoleit A. Mechanism of membrane damage by streptolysin-O. Infect. Immun. 1985, 47:52-60.
10. Billington S.J., Jost B.H., Songer J.G. Thiol-activated cytolysins: structure, function, and role in pathogenesis. FEMS Microbiol. Lett. 2000, 182:197-205.
11. Barlic A., Gutierrez-Aguirre I., Caaveiro J.M., Cruz A., Ruiz-Arguello M.B., Perez-Gil J., Gonzalez-Manas J.M. Lipid phase coexistence favors membrane insertion of equinatoxin-II, a pore-forming toxin from Actinia equina. J. Biol. Chem. 2004, 279:34209-34216.
12. Ishitsuka R., Kobayashi T. Cholesterol and lipid/protein ratio control the oligomerization of a sphingomyelin-specific toxin, lysenin. Biochemistry 2007, 46:1495-1502.
13. Chattopadhyay K., Bhattacharyya D., Banerjee K.K. Vibrio cholerae hemolysin. Implication of amphiphilicity and lipid-induced conformational change for its pore-forming activity. Eur. J. Biochem. 2002, 269:4351-4358.
14. Giesemann T., Jank T., Gerhard R., Maier E., Just I., Benz R., Aktories K. Cholesterol-dependent pore formation of Clostridium difficile toxin A. J. Biol. Chem. 2006, 281:10808-10815.
15. Giddings K.S., Zhao J., Sims P.J., Tweten R.K. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat. Struct. Mol. Biol. 2004, 11:1173-1178.
16. Giddings K.S., Johnson A.E., Tweten R.K. Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins. Proc. Natl. Acad. Sci. USA 2003, 100:11315-11320.
17. Heuck A.P., Hotze E.M., Tweten R.K., Johnson A.E. Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell 2000, 6:1233-1242.
18. Heuck A.P., Tweten R.K., Johnson A.E. Assembly and topography of the prepore complex in cholesterol-dependent cytolysins. J. Biol. Chem. 2003, 278:31218-31225.
19. Krasilnikov O.V., Muratkhodjaev J.N., Zitzer A.O. The mode of action of Vibrio cholerae cytolysin. The influences on both erythrocytes and planar lipid bilayers. Biochim. Biophys. Acta 1992, 1111:7-16.
20. Ikigai H., Nakae T. Assembly of the alpha-toxin-hexamer of Staphylococcus aureus in the liposome membrane. J. Biol. Chem. 1987, 262:2156-2160.
21. Kato I., Naiki M. Ganglioside and rabbit erythrocyte membrane receptor for staphylococcal alpha-toxin. Infect. Immun. 1976, 13:289-291.
22. Saha N., Banerjee K.K. Carbohydrate-mediated regulation of interaction of Vibrio cholerae hemolysin with erythrocyte and phospholipid vesicle. J. Biol. Chem. 1997, 272:162-167.
23. Howard S.P., Buckley J.T. Membrane glycoprotein receptor and hole-forming properties of a cytolytic protein toxin. Biochemistry 1982, 21:1662-1667.
24. Ji R.R., Siemers N.O., Lei M., Schweizer L., Bruccoleri R.E. SDRS - an algorithm for analyzing large-scale dose-response data. Bioinformatics 2011, 27:2921-2923.
25. Dennis J.E., Gay D.M., Welsch R.E. Algorithm 573. NL2SOL - An adaptive nonlinear least-squares algorithm. ACM Trans. Math. Software 1981, 7:369-383.
26. Somogyi M. Notes on sugar determination. J. Biol. Chem. 1952, 195:19-23.
27. Nollmann M., Gilbert R., Mitchell T., Sferrazza M., Byron O. The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin. Biophys. J. 2004, 86:3141-3151.
28. Heuck A.P., Savva C.G., Holzenburg A., Johnson A.E. Conformational changes that effect oligomerization and initiate pore formation are triggered throughout perfringolysin O upon binding to cholesterol. J. Biol. Chem. 2007, 282:22629-22637.
29. Waheed A.A., Shimada Y., Heijnen H.F., Nakamura M., Inomata M., Hayashi M., Iwashita S., Slot J.W., Ohno-Iwashita Y. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl. Acad. Sci. USA 2001, 98:4926-4931.
30. Shimada Y., Maruya M., Iwashita S., Ohno-Iwashita Y. The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur. J. Biochem. 2002, 269:6195-6203.
31. Jacobs T., Darji A., Frahm N., Rohde M., Wehland J., Chakraborty T., Weiss S. Listeriolysin O: cholesterol inhibits cytolysis but not binding to cellular membranes. Mol. Microbiol. 1998, 28:1081-1089.